MONTANARO, NICOLA
MONTANARO, NICOLA
DIP. DI FARMACOLOGIA
Comparative Safety Profiles of Biosimilars vs. Originators Used in Rheumatology: A Pharmacovigilance Analysis of the EudraVigilance Database
2025 Nikitina, Victoria; Laurini, Greta Santi; Montanaro, Nicola; Motola, Domenico
Overview of Orphan Medicines in European Union: An Analysis of Regulatory and Technical-Scientific Aspects
2025 Santi Laurini, Greta; Nikitina, Victoria; Broccoli, Massimiliano; Montanaro, Nicola; Motola, Domenico
Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab
2025 Nikitina, Victoria; Santi Laurini, Greta; Montanaro, Nicola; Motola, Domenico
Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data
2025 Santi Laurini, Greta; Nikitina, Victoria; Montanaro, Nicola; Motola, Domenico
Safety of fingolimod in patients with relapsing remitting multiple sclerosis: A descriptive analysis of data from the EudraVigilance database
2024 Nikitina, V.; Santi Laurini, G.; Montanaro, N.; Motola, D.
Comparative Safety Profiles of Oncology Biosimilars vs. Originators in Europe: An Analysis of the EudraVigilance Database
2023 Nikitina, Victoria; Santi Laurini, Greta; Montanaro, Nicola; Motola, Domenico
Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database
2023 Santi Laurini G.; Montanaro N.; Broccoli M.; Bonaldo G.; Motola D.
Safety of COVID-19 vaccines in pregnancy: a VAERS based analysis
2023 Santi Laurini G.; Montanaro N.; Motola D.
Safety Profile of Molnupiravir in the Treatment of COVID-19: A Descriptive Study Based on FAERS Data
2023 Santi Laurini G.; Montanaro N.; Motola D.
Safety profile of paediatric COVID-19 vaccines: An analysis of the US Vaccine Adverse Event Reporting System
2023 Nikitina V.; Santi Laurini G.; Montanaro N.; Motola D.
Level of therapeutic innovation from the registration studies of the new drugs for the prophylaxis of migraine
2022 Motola D.; Santi Laurini G.; Bonaldo G.; Montanaro N.
Safety profile of hydroxychloroquine used off-label for the treatment of patients with COVID-19: A descriptive study based on EudraVigilance data
2022 Motola D.; Bonaldo G.; Montanaro N.
Human papilloma virus vaccination in males: A pharmacovigilance study on the Vaccine Adverse Event Reporting System
2021 Bonaldo G.; Montanaro N.; Vaccheri A.; Motola D.
On criteria to evaluate the therapeutic innovation of drugs
2021 Motola D.; Montanaro N.
Removal of the EMA orphan designation upon request of the sponsor: cui prodest?
2021 Montanaro N.; Bonaldo G.; Motola D.
Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
2021 Bonaldo G.; Montanaro N.; AlbertoVaccheri; Motola D.
Non-commercial trials on medicines submitted to the Ethics Committee of the University Hospital of Bologna (Italy) along 8 years of activity: time to update rules and recommendations
2019 Montanaro N.; Bonaldo G.; Proni S.; Chiabrando G.; Motola D.
Six-year activity on approval of compassionate use of medicines by the Ethics Committee of the University Hospital of Bologna (Italy): time to update rules and recommendations
2017 Montanaro, Nicola; Melis, Mauro; Proni, Stefania; Chiabrando, Giacomo; Motola, Domenico
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions
2014 C. Biagi;V. Conti;N. Montanaro;M. Melis;E. Buccellato;M. Donati;A. Covezzoli;R. Amato;L. Pazzi;M. Venegoni;A. Vaccheri;D. Motola
Dronedarone-associated acute renal failure: evidence coming from the Italian spontaneous ADR reporting database
2013 Chiara Biagi;Mauro Venegoni;Mauro Melis;Elena Buccellato;Nicola Montanaro;Domenico Motola